GSK3α exhibits β-catenin and tau directed kinase activities that are modulated by Wnt

European Journal of Neuroscience

Volumn 24, Issue 12, 2006, Pages 3387-3392

  Asuni, Ayodeji A ^a,b   Hooper, Claudie ^a   Reynolds, C Hugh ^a   Lovestone, Simon ^a   Anderton, Brian H ^a   Killick, Richard ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's; Cell culture; Cell signalling; Diabetes; Transcription

Indexed keywords

AXIN; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHOTRANSFERASE; PROTEASOME; SCAFFOLD PROTEIN; TAU PROTEIN; WNT1 PROTEIN; AXIN PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 ALPHA; GLYCOGEN SYNTHASE KINASE 3 BETA; LUCIFERASE; REPRESSOR PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; TAUOPATHY; ANIMAL; CELL FRACTIONATION; CELL LINE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HAMSTER; METABOLISM; METHODOLOGY; PHYLOGENY; PHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; BETA CATENIN; BLOTTING, WESTERN; CELL LINE, TRANSFORMED; CRICETINAE; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; IMMUNOPRECIPITATION; LUCIFERASES; PHYLOGENY; REPRESSOR PROTEINS; SUBCELLULAR FRACTIONS; TAU PROTEINS; TRANSFECTION; WNT PROTEINS;

EID: 33845657460     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2006.05243.x     Document Type: Article

References (33)

1. Anderton, B.H., Betts, J., Blackstock, W.P., Brion, J.P., Chapman, S., Connell, J., Dayanandan, R., Gallo, J.M., Gibb, G., Hanger, D.P., Hutton, M., Kardalinou, E., Leroy, K., Lovestone, S., Mack, T., Reynolds, C.H. & Van Slegtenhorst, M. (2001) Sites of phosphorylation in tau and factors affecting their regulation. Biochem. Soc. Symp., 67, 73-80.
2. Behrens, J., Jerchow, B.A., Wurtele, M., Grimm, J., Asbrand, C., Wirtz, R., Kuhl, M., Wedlich, D. & Birchmeier, W. (1998) Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science, 280, 596-599.
3. Bhat, R.V., Budd Haeberlein, S.L. & Avila, J. (2004) Glycogen synthase kinase 3: a drug target for CNS therapies. J. Neurochem., 89, 1313-1317.
4. Bramblett, G.T., Goedert, M., Jakes, R., Merrick, S.E., Trojanowski, J.Q. & Lee, V.M. (1993) Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron, 10, 1089-1099.
5. Brion, J.P., Anderton, B.H., Authelet, M., Dayanandan, R., Leroy, K., Lovestone, S., Octave, J.N., Pradier, L., Touchet, N. & Tremp, G. (2001) Neurofibrillary tangles and tau phosphorylation. Biochem. Soc. Symp., 67, 81-88.
6. Cohen, P. (1999) The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transduction. Philos. Trans. R. Soc. Lond. B Biol. Sci., 354, 485-495.
7. Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M. & Hemmings, B.A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature, 378, 785-789.
8. Dajani, R., Fraser, E., Roe, S.M., Young, N., Good, V., Dale, T.C. & Pearl, L.H. (2001) Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell, 105, 721-732.
9. Doble, B.W. & Woodgett, J.R. (2003) GSK-3: tricks of the trade for a multitasking kinase. J. Cell Sci., 116, 1175-1186.
10. Dominguez, I., Itoh, K. & Sokol, S.Y. (1995) Role of glycogen synthase kinase 3 beta as a negative regulator of dorsoventral axis formation in Xenopus embryos. Proc. Natl Acad. Sci. USA, 92, 8498-8502.
11. Goedert, M., Jakes, R., Crowther, R.A., Cohen, P., Vanmechelen, E., Vandermeeren, M. & Cras, P. (1994) Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem. J., 301, 871-877.
12. Hanger, D.P., Hughes, K., Woodgett, J.R., Brion, J.P. & Anderton, B.H. (1992) Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett., 147, 58-62.
13. Hoeflich, K.P., Luo, J., Rubie, E.A., Tsao, M.S., Jin, O. & Woodgett, J.R. (2000) Requirement for glycogen synthase kinase-3beta in cell survival and NF- kappaB activation. Nature, 406, 86-90.
14. Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S. & Kikuchi, A. (1998) Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J., 17, 1371-1384.
15. Ishiguro, K., Omori, A., Takamatsu, M., Sato, K., Arioka, M., Uchida, T. & Imahori, K. (1992) Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments. Neurosci. Lett., 148, 202-206.
16. Jope, R.S. & Johnson, G.V. (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci., 29, 95-102.
17. Killick, R., Pollard, C.C., Asuni, A.A., Mudher, A.K., Richardson, J.C., Rupniak, H.T., Sheppard, P.W., Varndell, I.M., Brion, J.P., Levey, A.I., Levy, O.A., Vestling, M., Cowburn, R., Lovestone, S. & Anderton, B.H. (2001) Presenilin 1 independently regulates beta-catenin stability and transcriptional activity. J. Biol. Chem., 276, 48554-48561.
18. Lovestone, S., Reynolds, C.H., Latimer, D., Davis, D.R., Anderton, B.H., Gallo, J.M., Hanger, D., Mulot, S., Marquardt, B., Stabel, S., Woodgett, J.R. & Miller, C.J. (1994) Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr. Biol., 4, 1077-1086.
19. Mandelkow, E.M., Biernat, J., Drewes, G., Gustke, N., Trinczek, B. & Mandelkow, E. (1995) Tau domains, phosphorylation, and interactions with microtubules. Neurobiol. Aging, 16, 355-362; discussion 362-353.
20. Moon, R.T., Bowerman, B., Boutros, M. & Perrimon, N. (2002) The promise and perils of Wnt signaling through beta-catenin. Science, 296, 1644-1646.
21. Mudher, A., Chapman, S., Richardson, J., Asuni, A., Gibb, G., Pollard, C., Killick, R., Iqbal, T., Raymond, L., Varndell, I., Sheppard, P., Makoff, A., Gower, E., Soden, P.E., Lewis, P., Murphy, M., Golde, T.E., Rupniak, H.T., Anderton, B.H. & Lovestone, S. (2001) Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase. J. Neurosci., 21, 4987-4995.
22. Mukai, F., Ishiguro, K., Sano, Y. & Fujita, S.C. (2002) Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3beta. J. Neurochem., 81, 1073-1083.
23. Phiel, C.J., Wilson, C.A., Lee, V.M. & Klein, P.S. (2003) GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature, 423, 435-439.
24. Ruel, L., Bourouis, M., Heitzler, P., Pantesco, V. & Simpson, P. (1993) Drosophila shaggy kinase and rat glycogen synthase kinase-3 have conserved activities and act downstream of Notch. Nature, 362, 557-560.
25. Sakanaka, C., Weiss, J.B. & Williams, L.T. (1998) Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription. Proc. Natl Acad. Sci. USA, 95, 3020-3023.
26. Seidensticker, M.J. & Behrens, J. (2000) Biochemical interactions in the wnt pathway. Biochim. Biophys. Acta, 1495, 168-182.
27. Sun, W., Qureshi, H.Y., Cafferty, P.W., Sobue, K., Agarwal-Mawal, A., Neufield, K.D. & Paudel, H.K. (2002) Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules. J. Biol. Chem., 277, 11933-11940.
28. Troussard, A.A., Tan, C., Yoganathan, T.N. & Dedhar, S. (1999) Cell-extracellular matrix interactions stimulate the AP-1 transcription factor in an integrin-linked kinase- and glycogen synthase kinase 3-dependent manner. Mol. Cell Biol., 19, 7420-7427.
29. Utton, M.A., Vandecandelaere, A., Wagner, U., Reynolds, C.H., Gibb, G.M., Miller, C.C., Bayley, P.M. & Anderton, B.H. (1997) Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly. Biochem. J., 323, 741-747.
30. Wagner, U., Brownlees, J., Irving, N.G., Lucas, F.R., Salinas, P.C. & Miller, C.C. (1997) Overexpression of the mouse dishevelled-1 protein inhibits GSK-3beta-mediated phosphorylation of tau in transfected mammalian cells. FEBS Lett., 411, 369-372.
31. Welsh, G.I. & Proud, C.G. (1993) Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem. J., 294, 625-629.
32. Yost, C., Farr, G.H., 3rd, Pierce, S.B., Ferkey, D.M., Chen, M.M. & Kimelman, D. (1998) GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis. Cell, 93, 1031-1041.
33. Yost, C., Torres, M., Miller, J.R., Huang, E., Kimelman, D. & Moon, R.T. (1996) The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev., 10, 1443-1454.